Aspirin inhibits inducible nitric oxide synthase expression and tumour necrosis factor-α release by cultured smooth muscle cells

European Journal of Clinical Investigation

Volumn 29, Issue 2, 1999, Pages 93-99

  Sanchez De Miguel L ^a,b   De Frutos, T ^a,b   Gonzalez Fernandez F ^a,b   Del Pozo, V ^a,c   Lahoz, C ^a,c   Jimenez A ^a,b   Rico, L ^a,b   Garcia R ^a,c   Aceituno, E ^a,c   Millas I ^a,b   Gomez J ^a,b   Farre J ^a,b   Casado, S ^a,b   Lopez Farre A ^a,b,d  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Nephrology   (Spain)

^c Grupo de Trabajo Ecografía SoMaMFyC   (Spain)

^d Fundacion Jimenez Diaz   (Spain)

Author keywords

Aspirin; Nitric oxide; Nuclear factor B; Smooth muscle cells; Tumour necrosis factor

Indexed keywords

ACETYLSALICYLIC ACID; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR DISEASE; CATTLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME INHIBITION; GENE TRANSLOCATION; GRAFT REJECTION; HEART TRANSPLANTATION; INFLAMMATION; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTIC SHOCK; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BLOTTING, WESTERN; CARDIOVASCULAR DISEASES; CATTLE; CELLS, CULTURED; DNA-BINDING PROTEINS; EPOPROSTENOL; GENE EXPRESSION REGULATION; INTERLEUKIN-1; MUSCLE, SMOOTH; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032993694     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00425.x     Document Type: Article

References (34)

1. 1 Insel P. Analgesic-antipyrretics and antiinflammatory agents: drugs employed in the treatment of reumatoid arthritis and gout. In. Gilman AG, Rall T, Nies AS, Taylor P editors. The pharmacological basis of therapeutic, 8th edn. New York, MacGraw Hill Publishing; 1990. p.638-81.
2. 2 Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994;265:956-9.
3. 3 Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-41.
4. 4 Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993;70:36-41.
5. 5 Moncada S, Higgs A. The L-arginine nitric oxide pathway. N Engl J Med 1993;329:2002-12.
6. 6 Schini VB, Junquero DC, Scott-Burden T, Vanhoutte PM. Interleukin-1α induces the production of an L-arginine derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochem Biophys Res Commun 1991;176:114-21.
7. 7 Xie Q, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-8.
8. 8 Lewis NP, Tsao PS, Rickenbacher PR, et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 1996;93:720-9.
9. 9 Thiemermann C, Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysacharides in the rat in vivo. Eur J Pharmacol 1990;182:591-5.
10. 10 Haywood GA, Tsao PS, von der Leyen HE, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996;93:1087-94.
11. 11 Tanaka H, Swanson SJ, Sukhova G, Schoen FJ, Libby P. Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-alpha and proliferate during acute rejection of rabbit cardiac allografts. Am J Pathol 1995;147:617-26.
12. 12 Rus HG, Niculescu F, Vlaim R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1991;89:247-54.
13. 13 Warner SJC, Libby P. Human vascular smooth cells. Target for and source of tumor necrosis factor. J Immunol 1989;142:100-9.
14. 14 Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993;92:99-104.
15. 15 Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein-1 in cultured human endothelial cells. Circ Res 1995;76:980-6.
16. 16 Kolpakov V, Gordon D, Kulik TJ. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 1995;76: 305-9.
17. 17 López-Farré, A, Mosquera JRS, Sánchez de Miguel L, et al. Endothelial cells inhibit NO generation by vascular smooth muscle cells. Role of transforming growth factor-beta. Arterioscler Tromb Vasc Biol 1996;16:1263-8.
18. 18 LaemmLi NK. Change of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
19. 19 McGuire PG, Orkin RW. Isolation of rat aortic endothelial cells by primary explant techniques and their phenotypic modulation by defined substrates. Lab Invest 1987;57:94-104.
20. 20 Ziegler-Heitbrock HWL, Sternsdorf T, Liese J, et al. Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J Immunol 1993;151:6986-93.
21. 21 Cernadas MR, Sanchez de Miguel L, García-Durán M, et al. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res 1998;83:279-286.
22. 22 Weber C, Wolfgang E, Pietsch A, Weber PC. Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 1995;91:1914-7.
23. 23 Sherman MP, Aeberhard EE, Wong VZ, Griscavage JM, Ignarro LJ. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem Biophys Res Commum 1993;191:1301-8.
24. 24 Xie Q, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon and bacterial lipopolysaccharide. J Exp Med 1993;177:1779-84.
25. 25 Osnes LTN, Foss KB, Joø GB, et al. Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-κB/c-Rel nuclear translocation, and synthesis of tissue factor and tumor necrosis factor alpha in human monocytes. Thromb Haemost 1996;76:970-6.
26. 26 Amin AR, Vyas P, Attur M, et al. The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci USA 1995;92:7926-30.
27. 27 Prins BA, Hu RM, Nazario B, et al. Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem 1994;269:11938-44.
28. 28 Gallagher AM, Yu H, Printz MP. Bradykinin-induced reductions in collagen gene expression involve prostacyclin. Hypertension 1998;32:84-8.
29. 29 Yu H, Gallagher AM, Garfin PM, Printz MP. Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression. Hypertension 1997;30:1047-53.
30. 30 Beasley D, McGuiggin ME. Interleukin1 induces prostacyclin-dependent increases in cyclic AMP production and does not affect cyclic GMP production in human vascular smooth muscle cells. Cytokine 1995;7:417-26.
31. 31 Rayment NB, Moss E, Faulkner L, et al. Synthesis of TNF-alpha mRNA in the different micro-environments in this atherosmotous plaques. Cardiovasc Res 1996;32:1123-30.
32. 32 Renz H, Gong JH, Schmid A, Naim M, Gemza D. Release of tumor necrosis factor-alpha from macrophages. J Immunol 1988;141:2388-93.
33. 33 Weinberg JB, Granger DL, Pisetsky DS, et al. The role of nitric oxide in the pathogenesis murine autoimmune disease: increase nitric oxide production and nitric oxide synthase expression in MRL-1pr/1pr mice and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 1994;179:651-60.
34. 34 McCartney-Francis M, Allen JB, Mizel DE, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;178:749-54.